Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1401 - 1422 of 1422

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 600

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1701 - 1725 of 2132

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Istodax for Peripheral T-Cell Lymphoma - Details	pcodr_provfund_istodax_ptcl.pdf pcodr_romidepsin_istodax_ptcl_fn_rec.pdf pcodr_romidepsin_istodax_ptcl_fn_cgr.pdf pcodr_romidepsin_istodax_ptcl_fn_egr.pdf pcodr_romidepsin_istodax_ptcl_in_rec.pdf pcodr_romidepsin_istodax_ptcl_pagfdk.pdf pcodr_romidepsin_istodax_ptcl_fdk_celgene.pdf	Jun 26, 2015	Reimbursement Review	Complete	PC0048-000
Evolocumab	cdr_SR0441_Repatha.pdf SR0441_complete_Rapatha-Feb-23_16_e.pdf SR0441_Repatha_CL_Report.pdf SR0441_Repatha_PE_Report.pdf SR0441_Repatha_PI_Submissions.pdf	Jun 4, 2015	Reimbursement Review	Complete	SR0441-000
Bosulif for Chronic Myeloid Leukemia - Details	pcodr_profund_boustinib_bosulif_cml.pdf pcodr_bosutinib_bosulif_cml_fn_rec.pdf pcodr_bosutinib_bosulif_cml_fn_cgr.pdf pcodr_bosutinib_bosulif_cml_fn_egr.pdf pcodr_bosutinib_bosulif_cml_in_rec.pdf pcodr_bosutinib_bosulif_cml_pagfdk.pdf pcodr_bosutinib_bosulif_cml_fdk_pfizer.pdf pcodr_bosutinib_bosulif_cml_coi_cmlsc.pdf	Jun 4, 2015	Reimbursement Review	Complete	PC0039-000
Fluticasone furoate	cdr_SR0439_fluticasone_furoate.pdf SR0439_complete_Arnuity-Ellipta-Dec-21-15_e.pdf SR0439_Arnuity_Ellipta_CL_Report.pdf SR0439_Arnuity_Ellipta_PE_Report.pdf SR0439_Arnuity_Ellipta_PI_Submissions.pdf	May 4, 2015	Reimbursement Review	Complete	SR0439-000
Galsulfase (Drug Plan Submission)	cdr_SR0434_Naglazyme.pdf SR0434_complete_Naglazyme-Feb-23_16_e.pdf SR0434_Naglazyme_CL_Report.pdf SR0434_Naglazyme_PE_Report.pdf SR0434_Naglazyme_PI_Submissions.pdf	Apr 27, 2015	Reimbursement Review	Complete	SR0434-000
Rotigotine	cdr_SR0432_Neupro_Resubmission.pdf SR0432_complete_Neupro_Resb_Nov-24-15_e.pdf SR0432_Neupro_CL_Report_resub.pdf SR0432_Neupro_PE_Report_resub.pdf SR0432_Neupro_PI_Submissions.pdf	Apr 23, 2015	Reimbursement Review	Complete	SR0432-000
Pruning Emtree: Does Focusing Embase Subject Headings Impact Search Strategy Precision and Sensitivity?	ATS0022_Pruning Emtree_Methods_Project_e.pdf	Apr 16, 2015	Health Technology Review
Avastin for Cervical Cancer - Details	pcodr_provfund_avastin-cc.pdf pcodr-avastincc-fn-rec.pdf pcodr-avastin-cc-fn-cgr.pdf pcodr-avastin-cc-fn-egr.pdf pcodr-avastin-cc-in-rec.pdf pcodr-avastincc-pagfdk.pdf pcodr-avastincc-fdk-hlr.pdf pcodr-avastincc-fdk-occ.pdf pcodr-avastincc-coi-occ.pdf	Apr 8, 2015	Reimbursement Review	Complete	PC0045-000
Ivacaftor	cdr_SR0430_Kalydeco_R117H.pdf SR0430_complete_Kalydeco_R117H_Nov-23-15_e.pdf SR0430_KalydecoR117H_CL_Report.pdf SR0430_KalydecoR117H_PE_Report.pdf SR0430_KalydecoR117H_PI_Submissions.pdf	Apr 1, 2015	Reimbursement Review	Complete	SR0430-000
Apremilast	cdr_SR0437_Otezla_PsA.pdf SR0437_complete_Otezla_PsA-Dec-21-15_e.pdf SR0437_OtezlaPsA_CL_Report.pdf SR0437_OtezlaPsA_PE_Report.pdf SR0437_OtezlaPsA_PI_Submissions.pdf	Mar 31, 2015	Reimbursement Review	Complete	SR0437-000
Ivermectin	SR0429 Rosiver.pdf SR0429_complete_Rosiver_Nov-23-15_e.pdf SR0429_Rosiver_CL_Report.pdf SR0429_Rosiver_PE_Report.pdf SR0429 Rosiver_PI_Submissions_Consolidated_validated.pdf	Mar 30, 2015	Reimbursement Review	Complete	SR0429-000
Imbruvica for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (previously treated) - Details	pcodr-provfund_ibrutinib_imbruvica-CLL.pdf pcodr-ibrutinib-cll-sll-fn-rec.pdf pcodr-ibrutinib-cll-sll-fn-cgr.pdf pcodr-ibrutinib-cll-sll-fn-egr.pdf pcodr-ibrutinib-cll-sll-in-rec.pdf pcodr-ibrutinib-pagfdk.pdf pcodr-ibrutinib-fdk-janssen.pdf pcodr-ibrutinib-fdk-llsccllpag.pdf pcodr-ibrutinib-coi-llsc.pdf pcodr-ibrutinib-coi-cllpag.pdf pcodr-ibrutinib-cll-sll-fdk-lc.pdf pcodr-ibrutinib-cll-sll-coi-lc.pdf	Mar 20, 2015	Reimbursement Review	Complete	PC0043-000
Drugs for Pulmonary Arterial Hypertension	TR0006-PAH-InBrief-e.pdf TR0006_PAH_Protocol_e.pdf TR0006_PAH_ScienceReport.pdf TR0006_PAH_Recs_Report.pdf	Mar 16, 2015	Health Technology Review		TR0006-000
Nintedanib	cdr_SR0426_Ofev.pdf SR0426_Ofev_Oct-19-15.pdf SR0426_Ofev_CL_Report.pdf SR0426_Ofev_PE_Report.pdf SR0426_Ofev_PI_Submissions.pdf	Mar 13, 2015	Reimbursement Review	Complete	SR0426-000
Denosumab (Drug Plan Submission)	cdr_SR0414_Prolia-Men.pdf SR0414_cdr_complete_Prolia-Men_Sept-21-15-e.pdf SR0414_ProliaMen_CL_Report.pdf SR0414_ProliaMen_PE_Report.pdf SR0414_ProliaMen_PI_Submissions.pdf	Mar 10, 2015	Reimbursement Review	Complete	SR0414-000
Umeclidinium	cdr_SR0422_Incruse-Ellipta.pdf SR0422_Incruse_Ellipta_Sept-22-15.pdf SR0422_Incruse_Ellipta_CL_Report.pdf SR0422_Incruse_Ellipta_PE_Report.pdf	Mar 4, 2015	Reimbursement Review	Complete	SR0422-000
Solifenacin succinate / tamsulosin hydrochloride	cdr_SR0424_VesiFlow.pdf	Mar 2, 2015	Reimbursement Review	Withdrawn	SR0424-000
Aclidinium bromide/formoterol fumarate dihydrate	cdr_SR0423_Duaklir_Genuair.pdf SR0423_Duaklir_Genuair_Sept-22-15-e.pdf SR0423_DuaklirGenuair_PI.pdf SR0423_DuaklirGenuair_FDC_Report.pdf	Feb 24, 2015	Reimbursement Review	Complete	SR0423-000
Arzerra for Chronic Lymphocytic Leukemia - Details	pcodr_profund_ofatumumab_arzerra_cll.pdf pcodr-arzerra-cll-fn-rec.pdf pcodr-arzerra-cll-fn-cgr.pdf pcodr-arzerra-cll-fn-egr.pdf pcodr-arzerra-cll-in-rec.pdf pcodr-arzerra-cll-pagfdk.pdf pcodr-arzerra-cll-fdk-gsk.pdf pcodr-arzerra-cll-coi-llsc.pdf pcodr-arzerra-cll-coi-cllpag.pdf	Feb 23, 2015	Reimbursement Review	Complete	PC0038-000
Tocilizumab	cdr_SR0374_Actemra SC.pdf cdr_complete_SR0374_Actemra_SC_Feb-23-15.pdf SR0374_ActemraSC_CL_Report.pdf SR0374_ActemraSC_PE_Report.pdf SR0374_Actemra SC_PI_Submissions.pdf	Feb 23, 2015	Reimbursement Review	Complete	SR0374-000
Vedolizumab	cdr_SR0421_Entyvio.pdf SR0421_cdr_complete_Entyvio_Nov-2-15_e.pdf SR0421_Entyvio_CL_Report.pdf SR0421_Entyvio_PE_Report.pdf SR0421_Entyvio_PI_Submissions.pdf	Feb 20, 2015	Reimbursement Review	Complete	SR0421-000
Asunaprevir	SR0418 Sunvepra.pdf SR0418_complete_Sunvepra_Jul-20_16.pdf SR0418_Sunvepra_CL_Report.pdf SR0418_Sunvepra_PE_Report.pdf SR0418_Sunvepra_PI_Submissions.pdf	Feb 13, 2015	Reimbursement Review	Complete	SR0418-000
Daclatasvir	cdr_SR0417_Daklinza.pdf SR0417_cdr_complete_Daklinza_Sept-23-15_e.pdf SR0417_Daklinza_CL_Report.pdf SR0417_Daklinza_PE_Report.pdf SR0417 Daklinza_PI_Submissions.pdf	Feb 13, 2015	Reimbursement Review	Complete	SR0417-000
Eculizumab	cdr_SF0416_Soliris.pdf cdr-advice-Soliris-aHUS-June-2-2015.pdf SF0416_Soliris_aHUS_RfA_Report.pdf	Feb 9, 2015	Reimbursement Review	Complete	SF0416-000
Palonosetron	cdr_SR0415_Aloxi.pdf	Feb 6, 2015	Reimbursement Review	Withdrawn	SR0415-000